KCNQ2 and epilepsy: In summary, our study demonstrates that the neuronal isoform SGK1.1 selectively upregulates Kv7 subunit heteromers underlying the M-current and that activation of this kinase may provide a therapeutic target for treating epilepsy, particularly in patients carrying specific Kv7.2 epileptogenic mutations.